AiM April 2017

For the April 2017 issue of Activist Insight Monthly I wrote a secondary feature on how activists had chosen to ignore headline risk to again focus on agitating in the pharmaceutical and biotech industries.

Read the piece here.

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: